Recency
In big breaking news, China Tourism Group Duty Free is to acquire DFS’s travel retail businesses in Hong Kong and Macau and intangible assets in Greater China.
Interested?
Viewed by You are the first to view
AstraZeneca had already bagged the rights to the AbelZeta Pharma-partnered CAR-T cell therapy for most of the world. | The therapy in question, dubbed C-CAR031, is based on AstraZeneca’s own GPC3-targeting CAR-T.
Viewed by You are the first to view
Zurich Insurance Group has submitted an improved proposal of 1,280 pence in cash per share to acquire specialist insurer Beazley after the latter's Board
Interested?
Viewed by You are the first to view
Research contradicts President Trump’s claim that foreigners are footing the bill, and could weaken his hand in the dispute over Greenland
Viewed by You are the first to view
Some workers who have soured on the 9-to-5 schedule are interested in trying "microshifting," which may offer greater flexibility and control over their time.
Viewed by You are the first to view
The exchange is working with banks and seeking SEC sign-off to trade tokenized stocks and ETFs around the clock using private blockchains.
Viewed by You are the first to view
Discover chef and confectioner tips, plus delicious recipes and toppings, for taking the classic snack to the next level.
Viewed by You are the first to view
Thousands of pounds of ready-to-eat chicken products have been recalled due to potential contamination with listeria, officials say. The products were sold in 7 states.
Viewed by You are the first to view
Our editors tasted five store-bought rotisserie chickens to determine which one is the best.
Viewed by You are the first to view
Locals in Venezuela, as well as others living under unstable regimes, are turning to USDT as protection from political and economic uncertainties.
Viewed by You are the first to view
Viewed by You are the first to view
Buy stakes in companies combining scale, profitability, and durable demand across the AI technology stack.
Viewed by You are the first to view
Odds of bitcoin rising to $100,000 by the end of January plunged on the Polymarket, highlighting how the token is trading more like a risk asset than "digital gold."
Viewed by You are the first to view
Investors are valuing the startup at $4.8 billion as it is about to close another funding round, according to two people familiar with the matter.
Viewed by You are the first to view
Welcome to Monday’s update on quantum computing. As the year moves forward, attention is shifting from research milestones toward security planning, capital markets activity, and early commercial tools that already
Interested?
Viewed by You are the first to view
The decision is a major boon for affordable Chinese automakers like BYD that are steadily gaining ground in the European market.
Viewed by You are the first to view
Stellantis shares were largely up – as high as 93% in March 2024 – until reporting troubling financial results that year amid cost-cutting efforts and EVs.
Viewed by You are the first to view
Can you still buy a DJI drone in the US? (Yes.) Will you be able to buy future drones? (Maybe.) Here are the current drone dos and don’ts.
Viewed by You are the first to view
A newer fund run by an unconventional team at the venture firm is finding success focusing on infrastructure.
Viewed by You are the first to view
Opinion: As software power tools, AI agents may make people busier than ever before.
Interested?
Viewed by You are the first to view
75% of U.S. homes for sale are unaffordable to typical households.
Viewed by You are the first to view
He’s out of control – and if you don’t hang together to counter him, you’ll hang separately
Interested?
Viewed by You are the first to view
Trade tensions and a reversal in the AI boom are among the main risks to global economic growth, the IMF says.
Viewed by You are the first to view
As GLP-1 medications normalize smaller appetites and higher protein intake, national restaurant chains are quietly redesigning their menus — offering customers scaled-down portions at lower prices, whether they’re on the drugs or not
Viewed by You are the first to view